ArticleChina CDC weekly2025
Temporal Trends in Cardiovascular Disease Mortality Attributable to Ambient Particulate Matter Pollution - China, 1990-2021.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Cardiovascular disease (CVD) represents a major cause of mortality and disability in China's population. Ambient particulate matter pollution (APMP) has been established as a significant risk factor contributing to CVD development. What is added by this report?: Analysis of data from 1990 to 2021 reveals a substantial increase in APMP-attributable CVD mortality across China. While recent trends show decreased mortality risk associated with APMP-attributable CVD, birth cohort analysis demonstrates continued risk elevation in males but declining risk in females born after 1971. What are the implications for public health practice?: Enhanced surveillance and regulation of APMP, coupled with targeted health promotion strategies, are crucial, particularly for elderly populations and males who show increased vulnerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.